Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zheran Liu

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Frontiers in Immunology|July 28, 2025
Editorial: Opportunities and challenges of head and neck cancer treatment in the era of immune checkpoint inhibitorsZheran Liu, Lei Cai, Xingchen Peng
Frontiers in Oncology|April 22, 2022
The Development and Validation of a Nomogram Incorporating Clinical, Pathological, and Therapeutic Features to Predict Overall Survival in Patients With Penile Cancer: A SEER-Based StudyRuidan Li, Ke Cheng, Zhigong Wei, et al.
Frontiers in Oncology|December 16, 2021
Nasopharyngeal Carcinoma: Clinical Achievements and Considerations Among Treatment OptionsZheran Liu, Ye Chen, Yonglin Su, et al.
Frontiers in Immunology|March 24, 2025
Association of type 2 diabetes, hypertension, and hyperlipidemia with immune-related adverse events in patients undergoing immune checkpoint inhibitors therapyRuidan Li, Xiaoli Mu, Zheran Liu, et al.
Medicine|June 27, 2020
GLI1 expression in pancreatic ductal adenocarcinoma correlates the clinical significance and prognosis: A meta-analysisRuidan Li, Zheran Liu, Ye Chen, et al.
Frontiers in Pharmacology|November 30, 2023
The association between aspirin use and immune-related adverse events in specific cancer patients receiving ICIs therapy: analysis of the FAERS databaseHuaju Yang, Zheran Liu, Ruidan Li, et al.
Clinical Endocrinology|February 14, 2024
Tyrosine kinase inhibitors for radioiodine refractory differentiated thyroid cancer: A systematic review and meta-analysisJiayi Yu, Zheran Liu, Yonglin Su, et al.
Journal of Public Health (Oxford, England)|June 26, 2026
Antibiotic exposure and cancer risk: an umbrella review elucidating the direction of risk across 14 malignanciesTu Xu, Qing Xin, Jiacheng Li, et al.
Journal of Applied Clinical Medical Physics|July 9, 2022
Treatment plan comparison of volumetric-modulated arc therapy to intensity-modulated radiotherapy in lung stereotactic body radiotherapy using either 6- or 10-MV photon energiesZhigong Wei, Xingchen Peng, Ling He, et al.
Frontiers in Oncology|January 22, 2026
Pan-immune-inflammation value as an independent prognostic marker in patients with brain metastasesJiacheng Li, Menghan Liu, Yingtong Liu, et al.
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Frontiers in Immunology|July 28, 2025
Editorial: Opportunities and challenges of head and neck cancer treatment in the era of immune checkpoint inhibitorsZheran Liu, Lei Cai, Xingchen Peng
Frontiers in Oncology|April 22, 2022
The Development and Validation of a Nomogram Incorporating Clinical, Pathological, and Therapeutic Features to Predict Overall Survival in Patients With Penile Cancer: A SEER-Based StudyRuidan Li, Ke Cheng, Zhigong Wei, et al.
Frontiers in Oncology|December 16, 2021
Nasopharyngeal Carcinoma: Clinical Achievements and Considerations Among Treatment OptionsZheran Liu, Ye Chen, Yonglin Su, et al.
Frontiers in Immunology|March 24, 2025
Association of type 2 diabetes, hypertension, and hyperlipidemia with immune-related adverse events in patients undergoing immune checkpoint inhibitors therapyRuidan Li, Xiaoli Mu, Zheran Liu, et al.
Medicine|June 27, 2020
GLI1 expression in pancreatic ductal adenocarcinoma correlates the clinical significance and prognosis: A meta-analysisRuidan Li, Zheran Liu, Ye Chen, et al.
Frontiers in Pharmacology|November 30, 2023
The association between aspirin use and immune-related adverse events in specific cancer patients receiving ICIs therapy: analysis of the FAERS databaseHuaju Yang, Zheran Liu, Ruidan Li, et al.
Clinical Endocrinology|February 14, 2024
Tyrosine kinase inhibitors for radioiodine refractory differentiated thyroid cancer: A systematic review and meta-analysisJiayi Yu, Zheran Liu, Yonglin Su, et al.
Journal of Public Health (Oxford, England)|June 26, 2026
Antibiotic exposure and cancer risk: an umbrella review elucidating the direction of risk across 14 malignanciesTu Xu, Qing Xin, Jiacheng Li, et al.
Journal of Applied Clinical Medical Physics|July 9, 2022
Treatment plan comparison of volumetric-modulated arc therapy to intensity-modulated radiotherapy in lung stereotactic body radiotherapy using either 6- or 10-MV photon energiesZhigong Wei, Xingchen Peng, Ling He, et al.
Frontiers in Oncology|January 22, 2026
Pan-immune-inflammation value as an independent prognostic marker in patients with brain metastasesJiacheng Li, Menghan Liu, Yingtong Liu, et al.
Pageof 8